lobbying_activities: 1478996

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1478996	87d05ae7-fec0-4524-a101-47f75615f3d5	Q4	VAN HEUVELEN STRATEGIES, LLC	321874	ALLERGAN PLC (FORMERLY KNOWN AS ACTAVIS)	2013	fourth_quarter	LBR	Issues related to patent settlements and patent reform; S. 214 Preserve Access to Affordable Generics Act; S. 1720 Patent Transparency and Improvements Act of 2013; H.R. 3309 Innovation Act.	HOUSE OF REPRESENTATIVES,SENATE	50000		0	0	2014-01-15T19:19:23.500000-05:00